http://www.mdlinx.com/internal-medicine/medical-news-article/2015/06/26/atrial-fibrillation-stroke-warfarin/6196075/?
JACC - Journal of the American College of Cardiology, 06/26/2015
This
study sought to assess composite data regarding left atrial appendage
closure (LAAC) in 2 randomized trials compared to warfarin for
prevention of stroke, systemic embolism, and cardiovascular death in
patients with nonvalvular AF. In patients with nonvalvular atrial
fibrillation (NVAF) at increased risk for stroke or bleeding who are
candidates for chronic anticoagulation, LAAC resulted in improved rates
of hemorrhagic stroke, cardiovascular/unexplained death, and
nonprocedural bleeding compared to warfarin.
No comments:
Post a Comment